White House Demands Review of Draft Guidances

Drug Industry Daily
A A
The Trump administration has ordered federal agencies—including the FDA—to submit all pending guidance documents to the White House budget office, a move that some experts say could stall drug policy changes.

To View This Article:

Login

Subscribe To Drug Industry Daily